Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy

ClinicalTrials.gov ID: NCT00306722

Public ClinicalTrials.gov record NCT00306722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Dose-Controlled Study To Assess The Efficacy And Safety Of AQUAVAN® (Fospropofol Disodium) Injection For Minimal-To-Moderate Sedation In Patients Undergoing Flexible Bronchoscopy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Very often patients receive medication before a diagnostic, therapeutic, or surgical procedure to help them relax, keep them calm, and to relieve them from pain. This is called procedural sedation. During procedural (mild-to-moderate) sedation, a patient is first given a pain-relief medication (analgesic) and then a medication to help him/her relax and keep him/her calm (sedative). Propofol is the drug commonly used for sedation because it releases immediately into the blood stream and causes fast sedation. AQUAVAN (fospropofol disodium) is made as a slow release version of propofol with a longer duration of effect.

Study identification

NCT ID
NCT00306722
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eisai Inc.
Industry
Enrollment
250 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2006 (Type not available)
Primary completion
Not listed
Completion
May 2007 (Actual)
Last update posted
Nov 7, 2008

2006 – 2007

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
23
Facility City State ZIP Site status
Pulmonary Associates of Mobile, PC Mobile Alabama 36608 —
Precision Trials Phoenix Arizona 85032 —
Saddleback Memorial Medical Center Laguna Hills California 92653 —
USC Health Science Campus (USC University Hospital) Los Angeles California 90033 —
Pensacola Research Consultants, Inc. Pensacola Florida 32503 —
Acute Care Consultants Inc. Augusta Georgia 30909 —
Graves-Gilbert Clinic Bowling Green Kentucky 42101 —
Central Maine Pulmonary Associates Auburn Maine 04210 —
Berkshire Medical Center Pittsfield Maryland 01201 —
Hurley Medical Center Flint Michigan 48503 —
Keith Popovich, MD, PLLC Butte Montana 59701 —
International Heart Institue of MT Foundation Missoula Montana 59802 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
United Health Scrvices Hosptial, INC Johnson City New York 13790 —
Brody School of Medicine Greenville North Carolina 27834 —
ALL-TRIALS Clinical Research, LLC Winston-Salem North Carolina 27103 —
University of Cincinnati, The University Hospital Cincinnati Ohio 45267 —
Lowcountry Lung & Critical Care, PA Charleston South Carolina 29406 —
Medical University of South Carolina Charleston South Carolina 29425 —
Greenville Hospital System Greenville South Carolina 29605 —
South Carolina Pharmaceutical Research Spartanburg South Carolina 29303 —
Spartanburg Medical Research Spartanburg South Carolina 29303 —
The University of Texas Medical Branch Division of APICS Galveston Texas 77555 —
Johnston Memorial Hospital Pulmonary Research Abingdon Virginia 24210 —
Pulmonary Associates of Fredericksburg, Inc. Fredericksburg Virginia 22401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00306722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2008 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00306722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →